Shinji joined Simcyp/Certara in 2023, bringing more than 30 years of international experience in the pharmaceutical industry. He received his Ph.D. in Pharmaceutical Sciences from Tokyo University of Pharmacy and Life Sciences (Japan). His current research focuses on applying physiologically based pharmacokinetic (PBPK) modeling to predict drug-, gene-, and disease-drug interactions, as well as appropriate doses for pediatric patients. He has authored or co-authored over 50 peer-reviewed articles and book chapters, and served on the editorial board of Drug Metabolism and Disposition from 2015 to 2025.